Search research articles
Contact Us
Filters
Showing results (511-520 of 560) with videos related to
Page
of 56
Sort By:
EJNMMI Research
|
January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
Edward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
British Journal of Cancer
|
August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J W Valle, H Wasan, P Johnson, et al.
Cancer Medicine
|
March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer
Frankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2023
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of <sup>225</sup>Ac-J591
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, et al.
Molecular Neurobiology
|
August 19, 2018
Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models
Marielle H S Deurloo, Ekaterina Turlova, Wen-Liang Chen, et al.
AJNR. American Journal of Neuroradiology
|
June 8, 2023
Cost-Effectiveness Analysis of
J Rodriguez, G Martinez, S Mahase, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Identifying individuals at risk for surgical supravalvar aortic stenosis by polygenic risk score with graded phenotyping
D Liu, C B Mervis, M D Levin, et al.
Clinical Colorectal Cancer
|
August 17, 2015
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes
Constantinos T Sofocleous, Elena G Violari, Vlasios S Sotirchos, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Neuroimage
|
September 9, 2017
Spatial gene expression analysis of neuroanatomical differences in mouse models
Darren J Fernandes, Jacob Ellegood, Rand Askalan, et al.
Page
of 56
Search research articles
Search
Showing results (511-520 of 560) with videos related to
Sort By:
Page
of 56
EJNMMI Research
|
January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
Edward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
British Journal of Cancer
|
August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J W Valle, H Wasan, P Johnson, et al.
Cancer Medicine
|
March 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer
Frankie Ann Holmes, Beth A Hellerstedt, John E Pippen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2023
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of <sup>225</sup>Ac-J591
Scott T Tagawa, Charlene Thomas, A Oliver Sartor, et al.
Molecular Neurobiology
|
August 19, 2018
Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models
Marielle H S Deurloo, Ekaterina Turlova, Wen-Liang Chen, et al.
AJNR. American Journal of Neuroradiology
|
June 8, 2023
Cost-Effectiveness Analysis of
J Rodriguez, G Martinez, S Mahase, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2024
Identifying individuals at risk for surgical supravalvar aortic stenosis by polygenic risk score with graded phenotyping
D Liu, C B Mervis, M D Levin, et al.
Clinical Colorectal Cancer
|
August 17, 2015
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes
Constantinos T Sofocleous, Elena G Violari, Vlasios S Sotirchos, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Neuroimage
|
September 9, 2017
Spatial gene expression analysis of neuroanatomical differences in mouse models
Darren J Fernandes, Jacob Ellegood, Rand Askalan, et al.
Page
of 56